Interestingly, WFA had previously been identified as a potent inhibitor of C/EBPβ, suggesting that its effect in AML cells might also be due to indirect inhibition of MYB in a MYB-p300-C/EBPβ context [97]. Here, MYB is linked to acute myeloid leukemia.